ES2145132T3 - Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos. - Google Patents

Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.

Info

Publication number
ES2145132T3
ES2145132T3 ES94909807T ES94909807T ES2145132T3 ES 2145132 T3 ES2145132 T3 ES 2145132T3 ES 94909807 T ES94909807 T ES 94909807T ES 94909807 T ES94909807 T ES 94909807T ES 2145132 T3 ES2145132 T3 ES 2145132T3
Authority
ES
Spain
Prior art keywords
pct
active ingredients
stable
storage
supply system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94909807T
Other languages
English (en)
Inventor
Michael W Fountain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fountain Pharmaceuticals Inc
Original Assignee
Fountain Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fountain Pharmaceuticals Inc filed Critical Fountain Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2145132T3 publication Critical patent/ES2145132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN SISTEMA DE DISTRIBUCION DE VACUNAS QUE UTILIZA SDMC''S PARA DISTRIBUIR ANTIGENOS A LUGARES MUCOSOS PARA ESTIMULAR LA PRODUCCION DE INMUNOGLOBULINA. LAS VACUNAS COMPRENDEN SUBUNIDADES DE PATOGENO INCORPORADAS DENTRO DE LOS SDMC''S. SE DESCRIBE TAMBIEN UN METODO PARA LA PREPARACION DE UNA SOLUCION PRECURSORA ANTOESTABLE USADA PARA PREPARAR EL SISTEMA DE DISTRIBUCION DE VACUNAS Y `UTIL PARA ENCAPSULACION REMOTA DE INGREDIENTES ACTIVOS.
ES94909807T 1993-02-26 1994-02-25 Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos. Expired - Lifetime ES2145132T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2397193A 1993-02-26 1993-02-26

Publications (1)

Publication Number Publication Date
ES2145132T3 true ES2145132T3 (es) 2000-07-01

Family

ID=21818176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94909807T Expired - Lifetime ES2145132T3 (es) 1993-02-26 1994-02-25 Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.

Country Status (12)

Country Link
US (1) US5879703A (es)
EP (1) EP0688206B1 (es)
JP (1) JPH08507077A (es)
AT (1) ATE192331T1 (es)
AU (1) AU677826B2 (es)
CA (1) CA2157125A1 (es)
DE (1) DE69424279T2 (es)
DK (1) DK0688206T3 (es)
ES (1) ES2145132T3 (es)
PT (1) PT688206E (es)
SG (1) SG44911A1 (es)
WO (1) WO1994018950A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
IL126318A (en) 1996-03-29 2004-09-27 Emisphere Tech Inc Compounds and compositions for delivering active agents and some novel carrier compounds
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP1754488A1 (en) 1999-05-24 2007-02-21 Introgen Therapeutics, Inc. Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US10293056B1 (en) 2000-05-24 2019-05-21 Board Of Regents, The University Of Texas System Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
ES2625111T3 (es) * 2005-12-30 2017-07-18 Nuvessl Inc. Partículas nanolipídicas
WO2007092944A2 (en) * 2006-02-08 2007-08-16 Introgen Therapeutics, Inc. Compositions and methods involving gene therapy and proteasome modulation
US20140335166A1 (en) * 2013-05-08 2014-11-13 Michael W. Fountain Methods of Making and Using Nano Scale Particles
US9746471B2 (en) 2008-01-25 2017-08-29 Multivir Inc. P53 biomarkers
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
EP2451950B9 (en) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
CN107296792B (zh) * 2011-01-13 2021-07-27 变异生物技术公司 囊泡及由其产生之制剂的制备方法
EP2663327A4 (en) 2011-01-13 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
US9333675B2 (en) * 2012-01-10 2016-05-10 Hzo, Inc. Profiles for precursors to polymeric materials
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP4008354A1 (en) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Methods and compositions for therapeutic agents
KR20180016347A (ko) * 2015-04-13 2018-02-14 파운테인 테크놀로지스 인터내셔널, 엘엘씨 초-소형 지질 구조체의 생산을 위한 단일-단계 방법
US20200078427A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
US11458092B2 (en) 2018-12-14 2022-10-04 NuVessl, Inc. Composition with enhanced passenger molecule loading

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1695599A (en) * 1927-05-24 1928-12-18 Edward L Merzoian Dispenser
US2261877A (en) * 1940-05-15 1941-11-04 John G Erickson Dispensing device
US2712400A (en) * 1952-04-28 1955-07-05 Wayne C Stauffer Dispensing means for paste tubes
US3780911A (en) * 1972-01-03 1973-12-25 D Paige Dispensing apparatus for collapsible tube container
AU549154B2 (en) * 1982-12-07 1986-01-16 Motion, J.A.C. Collapsible tube expressor
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4755375A (en) * 1984-01-27 1988-07-05 Associated Universities, Inc. Method and kit for the selective labeling of red blood cells in whole blood with TC-99M
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
DE3775783D1 (de) * 1986-01-14 1992-02-20 Nederlanden Staat Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
IL90561A (en) * 1988-06-08 1993-08-18 Fountain Pharm Inc Method for making solvent dilution microcarriers
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren

Also Published As

Publication number Publication date
WO1994018950A1 (en) 1994-09-01
DK0688206T3 (da) 2000-09-25
EP0688206A1 (en) 1995-12-27
CA2157125A1 (en) 1994-09-01
JPH08507077A (ja) 1996-07-30
US5879703A (en) 1999-03-09
AU6250694A (en) 1994-09-14
DE69424279T2 (de) 2000-12-21
HK1012991A1 (en) 1999-08-13
SG44911A1 (en) 1997-12-19
AU677826B2 (en) 1997-05-08
ATE192331T1 (de) 2000-05-15
PT688206E (pt) 2000-08-31
EP0688206B1 (en) 2000-05-03
DE69424279D1 (de) 2000-06-08

Similar Documents

Publication Publication Date Title
ES2145132T3 (es) Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.
FI870155A0 (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
Auclair et al. POTENT INHIBITORY ACTIVITY OF [D-LEU6, DES-GLY-NH21Q] LHRH ETHYLAMIDE ON LH/hCG AND PRL TESTICULAR RECEPTOR LEVELS IN THE RAT
BR9408377A (pt) Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto
NO20014859L (no) Raskt dispergerbare doseringsformer inneholdende fiskegelatin
ES8601697A1 (es) Procedimiento para producir formas de preparados que contienen substancias con efecto antidiabetico por via oral
PT97476A (pt) Processo de preparacao de composicoes farmaceuticas para distribuicao sub-lingual de medicamentos a base de, entre outros, calcitonina, hormona de crescimento humano ou nifedipina
NZ217821A (en) Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
IL89602A0 (en) Compositions containing bioactive agents and methods for the preparation thereof
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
PL315181A1 (en) Method of producing pharmaceutical doses of hydrophobous substances in solid form
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
ES2171471T3 (es) Sistema para la administracion oral de desferrioxamina.
MY106722A (en) Sustained release formulations of water soluble peptides.
MX303646A (es) Sistema portador contra la hormona de liberacion de gonadotropina.
YU242589A (en) New substituted benzimidazole and process for obtaining thereof
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
ATE87467T1 (de) Pharmazeutische zubereitung.
RU97107089A (ru) Полипептидные соединения, содержащие d-2-алкилтриптофан, стимулирующий высвобождение гормона роста
BR9815404A (pt) Composição adjuvante para estimular uma eficiente resposta imunológica a uma substância antigênica, vacina para administração a um animal, processo para estimular uma resposta imunológica eficaz em um animal a uma substância antigênica, e, uso da composição adjuvante.
GB9906695D0 (en) Vaccine composition
Zorn et al. Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis.
ATE271378T1 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
ES2056337T3 (es) Utilizacion de antagonistas de receptores de tromboxano-a2 para evitar modificaciones degenerativas en el tejido penil.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688206

Country of ref document: ES